Atlas Trials

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

Clinical trial NCT07072988 · RECRUITING

Trial details

NCT number
NCT07072988
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Myasthenia Gravis, Generalized
Start date
2025-09-19
Primary completion
2027-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.